FRESHPET, INC. (FRPT): what the price assumes

In the published model solve dated 2026-Q2, anchored at $70.24, FRESHPET, INC. (FRPT) is priced for today's economics sustained for ~9.0 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-26.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/FRPT

Headline

FieldValue
TickerFRPT
CompanyFRESHPET, INC.
Sector / IndustryConsumer Defensive
Current price$70.24/sh
CompositionGrocery, Mass, International and Digital 81% / Pet Specialty and Club 19%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Must persist for9.0y
Multiple paid39x operating income

Solve inputs: computed at a 9.8% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: n/a

ReferenceValue
cohort percentile (of 69 peers)88

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.36x4expensive
Earnings1.71x3expensive
Relative1.38x5expensive
Growth1.13x3expensive

Families that justify the price: Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$62.091.13xyesFCF base $0.1B, growth 12% (input: historical growth), terminal g 4.0%, WACC 8.2%, 6yr projection
DCF Exit MultipleGrowth$77.820.90xyesExit EV/EBITDA: 17.2x / 19.2x / 21.2x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$75.690.93xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.1x / 22.0x / 25.9x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$44.071.59xyesBV/sh $25.68, ROE (TTM) 15.9%, ke 9.3%
Two-Stage Excess ReturnAsset$57.011.23xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$62.141.13xyesRev $1.1B, growth 12% (input: historical growth; tapered), Terminal P/S: 2.5x / 3.0x / 3.6x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$45.721.54xyesEPS $3.81, growth 2% (input: historical EPS growth), PEG=8.62 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$0.017024.00xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.00B × (1−26%) / WACC 8.2% → EPV (no growth) (excluded from median)
Residual IncomeAsset$58.031.21xyesBV $25.68 + 5yr PV of (ROE (TTM) 15.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$46.921.50xyes√(22.5 × EPS $3.81 × BVPS $25.68) — Graham's conservative floor
EV/EBITDA RelativeRelative$50.831.38xyesEBITDA $0.18B × sector EV/EBITDA 14.0x
FCF YieldEarnings$8.608.17xyesFCF $46.8M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$2.6726.31xyesSBC-adj FCF $0.02B (FCF $0.05B − SBC $0.03B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarnings$122.940.57xyesEPS $3.81 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$0.7494.92xyesBV $25.68 × (ROIC 0.2% / WACC 8.2%) (excluded from median)
P/Sales SectorRelative$46.251.52xyesRevenue $1.14B × sector P/S 2.0x
PEG Fair ValueRelative$142.880.49xyesEPS $3.81 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$41.191.71xyesEPS $3.81 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Freshpet (single operating segment)operatingenterprise1.1B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$45.9m
Net debt / NOPAT (after-tax)0.68x
Net debt / operating income (pre-tax)0.50x
Share count CAGR (dilution)6.6%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

One number decides this company, and it is not the profit line. In the March quarter net sales rose 13.1 percent to 297.6 million dollars, and the composition matters more than the total: volume contributed 14.6 percent while price and mix subtracted 1.5. Freshpet is selling more units, not charging more for the same ones. Set that against the shelf it competes on. CENT, the closest listed pet-focused comparison, grew revenue by roughly 0.2 percent over its trailing year. A packaged-food business taking units at that pace in a category growing at nothing is either doing something structurally different or borrowing from the future, and the fridge is the reason to think it is the former.

The mechanism is physical and hard to copy. As the company describes it, "Our products are primarily sold to consumers through a fast-growing network of company-owned branded refrigerators, known as Freshpet Fridges, located in our customers' stores". Freshpet buys the refrigerator, installs it, and owns the only cold real estate in the pet aisle, which reached approximately 30,235 retail stores at the end of 2025. A competitor cannot simply undercut on price into that space, because there is nowhere to put the product. Household penetration reached roughly 15.2 million United States households, which on any reasonable count of dog-owning homes leaves most of the market unserved.

What has changed lately is that the economics have started to arrive. Income from operations was 75.7 million dollars in 2025, 7 percent of net sales of 1,102.0 million, against 38.0 million and 4 percent the year before. Gross margin reached 40.5 percent in the March quarter from 39.4 percent, helped by lower input costs and better leverage on plant expenses, and selling and administrative spending fell to 39.1 percent of sales from 43.8 percent. The March quarter itself swung to operating income of 4.3 million dollars from a loss of 11.5 million a year earlier. Add the March quarter to the prior year and take out the year-ago quarter, and trailing operating profit reaches 91.5 million dollars. Those are the fixed costs of a decade of plant building finally being spread across enough volume.

Management raised its outlook on the back of it, lifting expected 2026 net sales growth to a range of 8 to 11 percent from 7 to 10 percent while holding adjusted EBITDA guidance at 205 to 215 million dollars and capital spending at 150 million. Cash generated by operations in the March quarter was 40.3 million dollars, up 35.5 million on the year. A company that spent a decade as a capital sink beginning to fund itself is a different investment proposition from the one most people remember.

The honest objection is that growth has slowed a long way from where it was and that negative price and mix is not a sign of strength. Both are true. What they do not change is the shape of the incremental unit: gross margin above 40 percent on a product distributed through refrigerators the company already owns and has already paid for means each additional case sold into an existing store carries very little extra cost.

Bear Case

Look at the capital structure before anything else, because it sets the clock. Freshpet has 402.5 million dollars of 3.0 percent convertible senior notes outstanding, and they mature on April 1, 2028. Against that it held 381.4 million dollars of cash at March 31, 2026, and it plans to spend 150 million dollars on capital projects during 2026 alone. The cash looks comfortable until you notice where a large part of it came from. It rose by 103.4 million dollars during the March quarter, and 95.5 million of that arrived as proceeds from selling the company's entire non-controlling interest in a privately held business. That is a source that fires once.

The reported bottom line is flattering in the same direction. Net income for the March quarter was 48.5 million dollars against a loss of 12.7 million a year earlier, and the company attributes the swing first of all to the gain on that equity sale, a pre-tax 62.0 million dollars. The full year before it carried its own one-off: at the end of 2025 Freshpet released most of the valuation allowance against its deferred tax assets and "recognized a deferred income tax benefit of $68.8 million for the year ended December 31, 2025". Neither item recurs. What recurs is 75.7 million dollars of operating profit on 1,102.0 million of sales, and 4.3 million in the March quarter. Read the business on that, and the reported earnings look considerably less established than the headline suggests.

Both ends of the supply chain are narrow. In 2025 two customers accounted for 25 percent and 10 percent of net sales, and roughly 69 percent of raw materials came from a concentrated group of suppliers. The company states the exposure without decoration: "We expect that a significant portion of our revenues will continue to be derived from a small number of customers and distributors; however, these customers or distributors may not continue to purchase our products in the same quantities as they have in the past." A grocery buyer at a 25 percent customer holds a lot of leverage over a supplier whose refrigerators sit in that buyer's stores at the supplier's expense.

All of which bears on the assumption in the price, which is that growth at a self-funding pace persists for a long stretch. Roughly 14 percent of comparable fast growers held a pace like that for even a decade, and Freshpet is already funding its growth with volume at flat-to-lower realized pricing rather than with pricing power. Meanwhile the share count has compounded about 6.6 percent a year since early 2022, so per-share progress lags the company's own progress. The bull case is not wrong about the fridge. It is exposed on how long the fridge keeps filling at a rate that justifies the capital going into new plants.

Valuation

Unusually for a company still spoken about as a growth story, the standard valuation frames are not far apart here, and none of them is far from the quote. The forward-growth methods land essentially on it, with the price only about 4 percent above that family's central estimate. The price sits about 23 percent above the asset-value family, about 26 percent above the peer-multiple family, and about 40 percent above the earnings-power methods. A spread that narrow says the disagreement is about pace rather than about whether the business is worth something.

Reading any of it requires getting the base right, and the base is the filed operating line rather than the reported bottom line. Income from operations was 75.7 million dollars for 2025 on net sales of 1,102.0 million, and adding the March 2026 quarter's 4.3 million while removing the year-ago quarter's 11.5 million loss brings trailing operating profit to 91.5 million dollars, roughly 8 percent of trailing sales. That is the number a multiple belongs on. The reported net income above it carries a 68.8 million dollar deferred tax benefit and a 62.0 million dollar gain on an asset sale, neither of which describes how the business runs.

Placed among its cohort the margin is now ordinary and the growth is not. CENT earns an operating margin near 8.2 percent on revenue that is roughly flat; BRBR earns about 12.5 percent while growing revenue near 6.4 percent; MZTI runs near 11.3 percent and TR near 13.7 percent. Freshpet's roughly 8 percent puts it at the lower end of that group on profitability while growing net sales at 13.1 percent in its most recent quarter, several times the pace of any of them. What the market is paying for is the presumption that the margin migrates toward the group while the growth does not.

The balance sheet reads differently depending on which build you use, and the basis is worth naming. On the company's own presentation there were 397.9 million dollars of borrowings outstanding at March 31, 2026, net of unamortized issuance costs, against 381.4 million dollars of cash; counting finance and other lease obligations alongside them, the funded total is higher and the position is a modest net borrowing rather than net cash either way. Interest expense of 14.1 million dollars in 2025 was covered several times over by that year's operating profit. The binding constraints are elsewhere: 150 million dollars of planned capital spending this year, and the April 1, 2028 maturity on the convertible notes.

Catalysts

First-quarter results on May 6, 2026 came with a raised outlook, which is not the usual accompaniment to a share price near these levels. Net sales rose 13.1 percent to 297.6 million dollars on volume growth of 14.6 percent, gross margin reached 40.5 percent, and cash generated by operations came to 40.3 million dollars, an improvement of 35.5 million on the year. Management lifted expected 2026 net sales growth to a range of 8 to 11 percent from 7 to 10 percent, held adjusted EBITDA guidance at 205 to 215 million dollars, and left capital spending guidance at 150 million.

Two dated items sit between that print and the next one. During the March quarter Freshpet sold its entire non-controlling interest in a privately held company after a third party acquired it, taking 95.5 million dollars of cash proceeds and a pre-tax gain of 62.0 million. And on June 22, 2026 the company announced that co-founder and President Scott Morris will retire effective October 20, 2026, remaining available through that date to hand over and serving as an adviser afterwards. A founder departure at a company whose distribution model was itself an invention is worth registering, even when the handover is orderly.

Second-quarter results are scheduled for August 5, 2026. The specific thing to read in them is the split inside the sales line rather than the sales line itself: whether volume keeps running ahead of the headline while price and mix subtract from it, or whether the gap starts to close. On July 8, 2026 Wells Fargo trimmed its target on the shares, citing an increase in the competitive landscape, and that is precisely the question the volume-versus-price split answers one way or the other.

Peer Cohorts (Per Segment, With Filing Citations)

Freshpet (single operating segment) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, filed May 6, 2026 · FY2025 Form 10-K · company earnings calendar · FY2025 Form 10-K; Q1 2026 earnings release, filed May 6, 2026 · Form 8-K, June 24, 2026 · analyst note, July 8, 2026

View the full interactive FRPT report on boothcheck